QUADRANT CAPITAL GROUP LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 149 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
900.0%0.00%
Q1 2022$1,000
-66.7%
90
-79.4%
0.00%
Q4 2021$3,000
+200.0%
436
+384.4%
0.00%
Q3 2021$1,00090
+260.0%
0.00%
Q2 2021$0250.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,827,078$82,205,0004.43%
Palo Alto Investors LP 4,663,324$79,416,0003.21%
Private Capital Advisors, Inc. 473,901$8,071,0002.23%
DOHENY ASSET MANAGEMENT /CA 215,445$3,669,0001.92%
Sandia Holdings, LLC 119,739$2,039,0000.96%
Capital Impact Advisors, LLC 102,006$1,744,0000.60%
Birchview Capital, LP 50,000$852,0000.55%
EMERALD ADVISERS, LLC 694,068$11,820,0000.43%
EMERALD MUTUAL FUND ADVISERS TRUST 647,307$11,024,0000.37%
Schonfeld Strategic Advisors LLC 418,100$7,121,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders